Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
71.61 CAD | +0.18% | -0.91% | +23.13% |
Apr. 15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
Apr. 12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.46% | 299B | |
+11.51% | 151B | |
+41.69% | 115B | |
+20.54% | 82.14B | |
+11.24% | 77.02B | |
+21.93% | 63.9B | |
+12.41% | 59.39B | |
+8.32% | 47.98B | |
+30.88% | 36.15B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Barclays Lowers Ovintiv's Price Target to $56 From $58, Maintains Overweight Rating